
Sign up to save your podcasts
Or


Ed Vess, R.Ph, QS/1®director of professional pharmacy affairs and OmniSYS® chief innovation officer David Pope, Pharm.D., discuss registering as a mass immunizer vs. a pharmacy immunizer and an update on allocation once a COVID-19 vaccine is approved in this week's update.
By QS/1Ed Vess, R.Ph, QS/1®director of professional pharmacy affairs and OmniSYS® chief innovation officer David Pope, Pharm.D., discuss registering as a mass immunizer vs. a pharmacy immunizer and an update on allocation once a COVID-19 vaccine is approved in this week's update.